Mursla is harnessing extracellular vesicle biology with its breakthrough ExoPheno™ platform to gain novel insights into diseases.
New logo symbolises the secretion of an extracellular vesicle from its parental cell along with its markers of origin.
Who are we?
Mursla is a breakthrough Extracellular Vesicle (EV) characterisation company based on a novel proprietary technology platform, ExoPheno™, which detects the multi-omics cargo of tissue-specific EVs in blood for various biomedical applications. Extracellular Vesicles have been shown to reflect the state of their cellular sources, transporting specific ‘-omics’ information (DNA, RNA, proteins, lipids and metabolites) either locally or to distant sites via the circulatory system, including blood.
Discover more: mursla.com